The Role of Arterial Hypertension in Mitral Valve Regurgitation-Reference-Cited by-同舟云学术

The Role of Arterial Hypertension in Mitral Valve Regurgitation

Published:2019-02-28 Issue:3 Volume:21 Page:
ISSN:1522-6417
Container-title:Current Hypertension Reports
language:en
Short-container-title:Curr Hypertens Rep

Author:

Katsi Vasiliki,Georgiopoulos Georgios,Magkas Nikolaos,Oikonomou Dimitrios,Virdis Agostino,Nihoyannopoulos Petros,Toutouzas Konstantinos,Tousoulis Dimitrios

Publisher

Springer Science and Business Media LLC

Subject

Internal Medicine

Link

http://link.springer.com/content/pdf/10.1007/s11906-019-0928-9.pdf

Reference102 articles.

1. Supino PG, Borer JS, Preibisz J, Bornstein A. The epidemiology of valvular heart disease: a growing public health problem. Heart Fail Clin. 2006;2(4):379–93.

2. Singh JP, Evans JC, Levy D, Larson MG, Freed LA, Fuller DL, et al. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study). Am J Cardiol. 1999;83(6):897–902.

3. •• Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP III, Guyton RA, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg. 2014;148(1):e1–e132. This comprehensive guideline document contains current recommendations of the American College of Cardiology/American Heart Association about the position of medical therapy in the management of mitral regurgiation as well as indications for interventional therapy.

4. •• Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, et al. 2017 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2017;38(36):2739–91. This is a guideline statement that summarizes the current recommendations of the European Society of Cardiology and the European Association for Cardio-Thoracic Surgery for the medical and interventional management of mitral regurgitation.

5. •• Harris KM, Pastorius CA, Duval S, Harwood E, Henry TD, Carabello BA, et al. Practice variation among cardiovascular physicians in management of patients with mitral regurgitation. Am J Cardiol. 2009;103(2):255–61. This is an interesting survey indicating a controversy between guidelines and everyday clinical practice, as it reported that a remarkable proportion of physicians administers medical therapy in MR patients without having a firm indication according to formal recommendations.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationship between valvular structure and biochemical indices of non-valvular atrial fibrillation and senile degenerative valvular heart disease;Journal of Thoracic Disease;2023-02

2. Myocardial External Efficiency in Asymptomatic Severe Primary Mitral Regurgitation Using¹¹C-Acetate PET;Journal of Nuclear Medicine;2023-01-05

3. Mitral Annular Elasticity Determines Severity of Regurgitation in Barlow’s Mitral Valve Disease;Journal of the American Society of Echocardiography;2022-10

4. Optimal Management of Mitral Regurgitation Due to Ruptured Mitral Chordae Tendineae in Patients With Hypertrophic Cardiomyopathy;Seminars in Thoracic and Cardiovascular Surgery;2022-05

5. Impact of Chest Wall Conformation on the Outcome of Primary Mitral Regurgitation due to Mitral Valve Prolapse;J CARDIOVASC ECHOGR;2022